Lifeline Drugs & Pharma Ltd

BSE: 506113
₹134.40
▼ -33.50 (-19.95%)
Aug. 27, 2015 · BSE · bse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
9/100
Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-16.7
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
Data unavailable.
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Ownership

1 of 1 met
  • Yes Promoter holding rose or was unchanged in the latest quarter

Value and momentum

0 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-20.0%
Low 134.4000 · High 134.4000
1W return
-41.6%
Low 134.4000 · High 247.9000
1M return
-32.5%
Low 134.4000 · High 247.9000
52W return
-48.6%
Low 134.4000 · High 330.0000
Lifetime High ₹584.3500 (Nov. 12, 2013)
Lifetime Low ₹8.5000 (Jan. 10, 2013)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
178.3
10D
194.2
20D
200.9
50D
200.2
100D
204.5
200D
222.7

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
92.1%
Month avg. delivery
85.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

134.40
Pivot
First resistance134.40
Second resistance134.40
Third resistance134.40
First support134.40
Second support134.40
Third support134.40
Day RSI27.0
Day MFI65.9
Day MACD-4.51
Day MACD signal3.26

Beta

1M1.04
3M0.21
1Y0.26
3Y-0.04

Price change analysis

↓ -32.5%
Over 1 Month
LowHigh
134.40247.90
↓ -27.7%
Over 3 Months
LowHigh
134.40254.00
↓ -39.7%
Over 6 Months
LowHigh
134.40267.60
↓ -48.6%
Over 1 Year
LowHigh
134.40330.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Data unavailable.

Shareholding pattern / Ownership

Shareholding summary

Mar 2018
  • Promoter0.07%

Largest holders

NameCategoryShares %Shares
STICKWELL INDIA PVT LTDPublic4.9800%1804837
LINUS HOLDINGS LIMITEDPublic4.9700%1801984
SURESHAM VINIMAY PRIVATE LIMITEDPublic4.9600%1799124
SHIVMANI VINIMAY PRIVATE LIMITEDPublic4.1700%1510319
GOODPOINT IMPEX PRIVATE LIMITEDPublic3.8200%1383495

As of March 31, 2018. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 0.07% in Mar 2018 qtr

All shareholding details →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

  • RSI in oversold territory (27.0) -- a technical rebound zone

Threats

  • Down 48.6% over the past year

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Lifeline Drugs & Pharma Ltd

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.